Sanofi
| (at previous day's close) |
| Market Cap. |
106,247.36 |
m |
| Shares In Issue |
1,285.04 |
m |
| Prev. Close |
82.45 |
|
| PE Ratio |
25.14 |
|
| Dividend Yield |
3.55 |
% |
| EPS – basic |
3.28 |
c |
| Dividend PS |
2.93 |
c |
| Dividend Cover |
1.12 |
|
| Cash Flow PS |
6.94 |
c |
| Return On Equity (ROE) |
7.73 |
% |
| Operating Margin |
- |
% |
| PEG Factor |
- |
|
| EPS Growth Rate |
- |
% |
| Dividend PS Growth Rate |
2.81 |
% |
| Net Debt |
34,852.00 |
m |
| Gross Gearing |
43.11 |
% |
| Quick Assets |
12,311.00 |
m |
| Net Working Cap |
85,496.00 |
m |
| Intangibles / Fixed Assets |
11.02 |
% |
| Turnover PS |
26.88 |
c |
| Pre-Tax Profit PS |
0.00 |
c |
| Retained Profit PS |
- |
c |
| Cash PS |
720.52 |
c |
| Net Cash PS |
-588.77 |
c |
| Net Tangible Asset Value PS* |
364.27 |
c |
| Net Asset Value PS |
7,962.46 |
c |
| Spread |
0.63 (0.76%) |
|
| *Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies. |
|
Sanofi Balance Sheet (Dec 31 2015)
Sanofi Share Price
| Sample Period † |
High |
Low |
| 1 week |
80.96 |
83.28 |
| 4 weeks |
79.91 |
85.90 |
| 12 weeks |
71.74 |
85.90 |
| 1 year |
71.74 |
85.90 |
Sanofi (5 years)
|
Sanofi Historic Returns
| Period * |
Open |
Change |
% |
Open Avg. |
Avg. Daily Vol [m] |
Total Vol. [m] |
VWAP |
| 1 week |
81.85 |
0.83 |
1.01 |
81.97 |
1,975,858.00 |
|
82.01 |
| 4 weeks |
80.21 |
2.47 |
3.08 |
82.72 |
2,651,891.00 |
|
82.89 |
| 12 weeks |
76.06 |
6.62 |
8.70 |
78.98 |
2,400,325.00 |
|
79.22 |
| 26 weeks |
75.31 |
7.37 |
9.79 |
77.12 |
2,427,515.00 |
|
77.27 |
| 1 year |
75.25 |
7.43 |
9.87 |
76.84 |
2,415,122.00 |
|
76.95 |
| 3 years |
68.26 |
14.42 |
21.13 |
76.43 |
2,477,070.00 |
|
76.04 |
| 5 years |
80.50 |
2.18 |
2.71 |
78.09 |
2,732,880.00 |
|
78.10 |
| * periods calculated are whole weeks rather than calendar months |
|
|
Sanofi Key Management Ratio
|
Sanofi Investment Ratios
| (Market value analysis) at previous day's close |
|
PQ Ratio |
17.10 |
|
|
PE Ratio |
25.14 |
|
|
Tobin's Q Ratio |
1.04 |
|
|
Tobin's Q Ratio (excl. intangibles) |
2.09 |
|
|
Dividend Yield |
3.55 |
% |
|
Market-to-Book Ratio |
1.04 |
|
|
Price-to-Pre-Tax Profit PS |
202,082.39 |
|
|
Price-to-Retained Profit PS |
- |
|
|
Price-to-Cash Flow PS |
11.88 |
|
|
Price-to-Sales PS |
3.07 |
|
|
Price-to-Net Tangible Asset Value PS |
0.23 |
|
|
Price-to-Cash PS |
0.11 |
|
|
Net Working Capital PS |
66.53 |
|
|
Price Pct to Working Capital PS |
1.24 |
% |
|
Earnings Yield |
0.04 |
% |
|
Average PE |
- |
|
|
Years in Average PE |
- |
|
|
PE to PE average |
- |
% |
|
Sanofi Financial Ratios
| (Leverage Ratios) |
|
Debt Ratio |
79.01 |
% |
|
Debt-to-Equity Ratio |
0.60 |
|
|
Debt-to-Equity Ratio (excl. Intgbl) |
5.26 |
|
|
Debt-to-Equity Market Value |
0.33 |
|
|
Net Gearing |
34.06 |
% |
|
Net Gearing (excl. Intangibles) |
68.69 |
% |
|
Gross Gearing |
43.11 |
% |
|
Gross Gearing (excl. Intangibles) |
86.94 |
% |
|
Gearing Under 1 Year |
16.44 |
% |
|
Gearing Under 1 Year (excl. Intgbl) |
33.16 |
% |
|
Assets / Equity |
1.76 |
|
|
Cash / Equity |
0.16 |
|
|
(Liquidity Ratios) |
|
Net Working Capital to Total Assets |
83.56 |
% |
|
Current Ratio |
2.19 |
|
|
Quick Ratio (Acid Test) |
1.80 |
|
|
Liquidity Ratio |
0.55 |
|
|
Cash & Equiv / Current Assets |
25.16 |
% |
|
(Solvency Ratios) |
|
Enterprise Value |
1,242,743.55 |
m |
|
Sales |
0.26 |
|
|
CFO / Attributable Profit |
- |
|
|
CFO / Assets |
0.00 |
|
|
CFO / Debt |
0.00 |
|
|
Total Debt / Equity Market Value |
0.42 |
|
|
Total Debt / Sales |
1.28 |
|
|
Total Debt / Pre-Tax Profit |
8,413,312.99 |
|
|
Total Debt |
44,111.00 |
m |
|
Total Debt / Net Current Assets |
0.52 |
% |
|
(Dodds – Graham Ratios) |
|
|
|
3 yr Compound Earnings Growth |
- |
% |
|
5 yr Compound Earnings Growth |
- |
% |
|
10 yr Compound Earnings Growth |
- |
% |
|
Earn drops > 5% in 10yrs |
10.00 |
|
|
Beta (60-Mnth) |
Beta (36-Mnth) |
| - |
- |
|
Alpha (60-Mnth) |
Alpha (36-Mnth) |
| - |
- |
|
Sanofi Operating Ratios
| (Profitability Ratios) |
|
Return On Capital Employed (ROCE) |
0.00 |
% |
|
Return On Assets (ROA) |
- |
% |
|
Net Profit Margin |
- |
% |
|
Assets Turnover |
0.00 |
|
|
Return On Equity (ROE) |
7.73 |
% |
|
Return On Investment (ROI) |
- |
% |
|
Dividend Payout Ratio |
89.33 |
% |
|
Plowback Ratio |
10.67 |
% |
|
Growth from Plowback Ratio |
82.45 |
% |
|
Net Income of Revenues |
- |
% |
| (Asset Utilisation Multiples) |
|
Shareholders Equity Turnover |
0.00 |
|
|
Fixed Assets Turnover |
0.00 |
|
|
Current Assets Turnover |
0.00 |
|
|
Net Working Capital Turnover |
0.00 |
|
|
Inventory Turnover |
0.00 |
|
| (Other Operating Ratios) |
|
Total Assets-to-Sales |
2.96 |
|
|
Debtors-to-Sales |
25.63 |
% |
|
Debt Collection Period |
93.55 |
Days |
|
Sanofi Dividends
| Type |
Curr. |
Dividend Amount |
Period Start |
Period End |
Total Dividend Amount |
| Final |
EUR |
2.93 |
Dec 31 2014 |
Dec 31 2015 |
2.93 |
| Final |
EUR |
2.85 |
Dec 31 2013 |
Dec 31 2014 |
2.85 |
| Final |
EUR |
2.80 |
Dec 31 2012 |
Dec 31 2013 |
2.80 |
| Final |
EUR |
2.77 |
Dec 31 2011 |
Dec 31 2012 |
2.77 |
| Final |
EUR |
2.65 |
Dec 31 2010 |
Dec 31 2011 |
2.65 |
| Final |
EUR |
2.50 |
Dec 31 2009 |
Dec 31 2010 |
2.50 |
| Final |
EUR |
2.40 |
Dec 31 2008 |
Dec 31 2009 |
2.40 |
| Final |
EUR |
2.20 |
Dec 31 2007 |
Dec 31 2008 |
2.20 |
|
Sanofi Fundamentals
|
| |
Dec 31 2012 (EUR) |
|
Dec 31 2013 (EUR) |
|
Dec 31 2014 (EUR) |
|
Dec 31 2015 (EUR) |
|
|
Turnover |
34,947.00 |
100.00% |
|
32,951.00 |
100.00% |
|
33,770.00 |
100.00% |
|
34,542.00 |
100.00% |
m |
|
Pre Tax Profit |
5,877.00 |
16.82% |
|
4,603.00 |
13.97% |
|
5,731.00 |
16.97% |
|
5,243.00 |
15.18% |
m |
|
Attributable Profit |
- |
-% |
|
- |
-% |
|
- |
-% |
|
- |
-% |
m |
|
Retained Profit |
- |
-% |
|
- |
-% |
|
- |
-% |
|
- |
-% |
m |
|
Eps – Basic |
3.76 |
|
|
2.81 |
|
|
3.34 |
|
|
3.28 |
|
|
|
Eps – Diluted |
3.74 |
|
|
2.78 |
|
|
3.30 |
|
|
3.25 |
|
|
|
Dividends per Share |
2.77 |
|
|
2.80 |
|
|
2.85 |
|
|
2.93 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sanofi Balance Sheet
| |
Dec 31 2012 (EUR) |
|
Dec 31 2013 (EUR) |
|
Dec 31 2014 (EUR) |
|
Dec 31 2015 (EUR) |
|
|
  |
|
  |
|
  |
|
  |
|
|
|
| |
Dec 31 2012 (EUR) |
|
Dec 31 2013 (EUR) |
|
Dec 31 2014 (EUR) |
|
Dec 31 2015 (EUR) |
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
- |
-% |
|
- |
-% |
|
- |
-% |
|
- |
-% |
m |
Intangibles |
58,265.00 |
58.03% |
|
52,529.00 |
54.68% |
|
53,740.00 |
55.18% |
|
51,583.00 |
50.41% |
m |
|
Fixed Investments |
3,585.00 |
3.57% |
|
4,583.00 |
4.77% |
|
4,189.00 |
4.30% |
|
4,681.00 |
4.57% |
m |
Current Assets – Other |
16,015.00 |
15.95% |
|
15,305.00 |
15.93% |
|
16,332.00 |
16.77% |
|
21,429.00 |
20.94% |
m |
|
Stocks |
6,379.00 |
6.35% |
|
6,352.00 |
6.61% |
|
6,562.00 |
6.74% |
|
6,516.00 |
6.37% |
m |
|
Debtors |
9,604.00 |
9.57% |
|
8,854.00 |
9.22% |
|
9,010.00 |
9.25% |
|
8,853.00 |
8.65% |
m |
Cash & securities |
6,559.00 |
6.53% |
|
8,442.00 |
8.79% |
|
7,559.00 |
7.76% |
|
9,259.00 |
9.05% |
m |
|
Other assets |
107.00 |
0.11% |
|
29.00 |
0.03% |
|
69.00 |
0.07% |
|
5,801.00 |
5.67% |
m |
|
|
|
TOTAL |
100,407.00 |
100.00% |
|
96,065.00 |
100.00% |
|
97,392.00 |
100.00% |
|
102,321.00 |
100.00% |
m |
|
|
LIABILITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Creditors – Short |
13,860.00 |
24.12% |
|
13,957.00 |
24.48% |
|
13,032.00 |
23.16% |
|
16,825.00 |
28.90% |
m |
Creditors – Long |
29,075.00 |
50.59% |
|
25,094.00 |
44.01% |
|
28,092.00 |
49.93% |
|
27,286.00 |
46.88% |
m |
|
|
TOTAL |
42,935.00 |
74.71% |
|
39,051.00 |
68.49% |
|
41,124.00 |
73.09% |
|
44,111.00 |
75.78% |
m |
|
|
EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Minority Interest |
-57,338.00 |
-99.77% |
|
-56,885.00 |
-99.77% |
|
-56,120.00 |
-99.74% |
|
-58,049.00 |
-99.72% |
m |
|
Capital Reserves |
57,338.00 |
99.77% |
|
56,885.00 |
99.77% |
|
56,120.00 |
99.74% |
|
58,049.00 |
99.72% |
m |
|
TOTAL |
57,472.00 |
100.00% |
|
57,014.00 |
100.00% |
|
56,268.00 |
100.00% |
|
58,210.00 |
100.00% |
m |
|
|
Sanofi Cash Flow Statement
|
Dec 31 2012 (EUR) |
|
Dec 31 2013 (EUR) |
|
Dec 31 2014 (EUR) |
|
Dec 31 2015 (EUR) |
|
|
Operating CF |
8,171.00 |
|
6,954.00 |
|
7,690.00 |
|
8,920.00 |
|
|
Investing CF |
-1,587.00 |
|
-1,273.00 |
|
-3,458.00 |
|
-3,265.00 |
|
|
Financial CF |
-4,351.00 |
|
-3,726.00 |
|
-5,182.00 |
|
-3,593.00 |
|
|
Net change CF |
2,233.00 |
|
1,955.00 |
|
-950.00 |
|
2,062.00 |
|
|
|
|
|
|
|
|
|
|
|
Sanofi Employee Data
|
Dec 31 2012 (EUR) |
|
Dec 31 2013 (EUR) |
|
Dec 31 2014 (EUR) |
|
Dec 31 2015 (EUR) |
|
|
Number of employees |
112,128.00 |
|
112,128.00 |
|
113,496.00 |
|
115,631.00 |
|
|
Sales per employee |
0.31 |
|
0.29 |
|
0.30 |
|
0.30 |
m |
|
|
|
|
|
|
|
|
|
|
|
